-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
DICE Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2020 to 2022.
- DICE Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2023 was -$34.8M, a 61.8% decline year-over-year.
- DICE Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2023 was -$104M, a 41.5% decline year-over-year.
- DICE Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$83.9M, a 71.3% decline from 2021.
- DICE Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$49M, a 106% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)